Advac, LLC, is a vaccine research company founded by Sang-Moo Kang, professor in the Institute for Biomedical Sciences. Kang is focused on designing and developing effective vaccines against viral diseases such as influenza and respiratory syncytial virus (RSV), improving understanding of vaccine-induced protective immune mechanisms, studying pathogen-induced inflammation, and developing anti-inflammatory therapeutics.
Cell Constructs, Inc., was formed in 2008 to develop and evaluate proof-of-principle product concepts based upon the use of adult human stem cells. Its biomaterials facilitate efficient use of stem cells in regenerative healing and tissue engineering applications. CCI is developing ProgenaGraft™ for the regenerative healing of chronic wounds such as diabetic foot ulcers.
Chembind, LLC, is a pharmaceutical company dedicated to promoting the research and development of sugar chemistry, glycobiology and medicine. The company also works to invent and design new isotope labeled compounds, antibody-drug conjugates and in vitro diagnosis reagents.
NanoResearch, Inc., works to invent and design new manufacturing enterprise and/or license new nanomaterials, energy storage materials, energy storage devices and smart mechanical products.
ProDa BioTech, LLC
Research Projects International, LLC
ResonanceDx, Inc., is a point-of-care diagnostic device startup company. Their novel, flexible testing platform can provide rapid results to support immediate clinical decision-making.